Myasthenia gravis
RecruitingStudy on the Effects of Iptacopan in Patients with Generalized Myasthenia Gravis
- Disease:Myasthenia gravis
- Substances:Iptacopan
France- Participants:18–64 years · 65+ years
- Substances:Iptacopan
- Sponsor:Novartis Pharma AG
Rare diseases
Investigational molecules
Locations
Back to France66 clinical trials in Garches, France across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)
France
France
France
France
France
France
France
France
France
France
France
FranceThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on innovative treatments for neuromuscular conditions and movement disorders, including studies on Spinal Muscular Atrophy and Myasthenia Gravis. Research examines novel drug delivery systems and therapeutic approaches for improving patient outcomes.
Groundbreaking research in intensive care focusing on treating severe conditions like septic shock and immunosuppression. Studies evaluate new therapeutic approaches for improving survival rates and patient outcomes in critical care settings.
Innovative clinical trials targeting rare genetic conditions including Pompe Disease and Fabry Disease. Research focuses on enzyme replacement therapies and novel treatment approaches to improve patient quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.